[144] Lexeo Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Lexeo Therapeutics (LXEO) filed a Form 144 reporting a proposed sale of 2,848 common shares held by an insider following restricted stock vesting. The shares have an aggregate market value of $13,295.03 and represent a small fraction of the company's outstanding common stock of 54,001,214 shares. The filing lists Fidelity Brokerage Services LLC as the broker and an approximate sale date of 08/18/2025. The acquisition source is shown as restricted stock vesting on 08/15/2025 with payment characterized as compensation. No other sales in the past three months were reported.

Insights

Securities Analyst

TL;DR: Insider plans to sell a de minimis position from recently vested restricted stock; likely immaterial to valuation.

This Form 144 documents a small, post-vesting sale of 2,848 shares valued at $13,295.03 using Fidelity as broker with an estimated sale date of 08/18/2025. Relative to 54.0 million shares outstanding, the position is immaterial and does not reflect recent prior sales. The filing contains standard Rule 144 representations and no indications of material undisclosed information. For investors, this appears to be routine compensation-related liquidity rather than a signal of company-wide issues.

Corporate Governance Expert

TL;DR: Routine insider liquidity from vested awards; disclosure matches Rule 144 mechanics and includes required attestations.

The notice shows the securities were acquired via restricted stock vesting and paid as compensation on 08/15/2025, consistent with equity compensation practices. The filer attests to lack of material nonpublic information and indicates no aggregated sales in the prior three months. Procedurally, the filing is complete for a small sale and raises no governance red flags based on the disclosed facts.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2848	13295.03	54001214	08/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Restricted Stock Vesting	Issuer			2848	08/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)